California Legal Codes and Statutes

§ 11839.2

Amended by Stats. 2024, Ch. 634, Sec. 4. (AB 2115) Effective September 27, 2024.

The following medications are authorized for use in narcotic replacement therapy and medication-assisted treatment by licensed narcotic treatment programs:

(a)Methadone.
(b)Buprenorphine products or combination of products approved by the federal Food and Drug Administration for maintenance or detoxification of opioid dependence.
(c)Any other medication approved by the federal Food and Drug Administration for the purpose of narcotic replacement treatment or medication-assisted treatment of substance use disorders.
(d)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section by means of plan or provider bulletins, or similar instructions. The department shall adopt regulations by no later than January 1, 2021.

Cite this section

Cal. Health & Saf. Code § 11839.2 (2026)
https://ca.codecond.com/codes/hsc/division-10-5-alcohol-and-other-drug-programs/part-2-state-governments-role-to-alleviate-problems-related-to-the-inappropriate-use-of-alcoholic-beverages-and-other-drug-use/chapter-10-narcotic-treatment-programs/article-1-narcotic-treatment-programs/section-11839.2

Other sections in Article 1 - Narcotic Treatment Programs

§ 11839§ 11839.01§ 11839.1§ 11839.2§ 11839.10§ 11839.11§ 11839.12§ 11839.13§ 11839.14§ 11839.15§ 11839.16§ 11839.17§ 11839.18§ 11839.19§ 11839.20§ 11839.21§ 11839.22

This content is for reference, learning, and study purposes only. All legal text should be verified against the official California Legislative Information website, which is the authoritative source for California law. Data last processed: February 8, 2026.